For example, dipeptidyl peptidase-4 (DPP-4) inhibitors and sodium-glucose co-transporter 2 (SGLT-2) inhibitors have a low risk of hypoglycaemia; in contrary, sulfonylureas and thiazolidinediones may cause weight gain [3]. The gene discussed is DPP4; the disease is Hypoglycemia.